|
MEF2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.498000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.321800E-03 |
| Normal-vs-Stage2 |
2.960600E-01 |
| Normal-vs-Stage3 |
7.628300E-02 |
| Normal-vs-Stage4 |
1.015600E-03 |
| Stage1-vs-Stage2 |
6.974400E-01 |
| Stage1-vs-Stage3 |
2.17129999999788E-05 |
| Stage1-vs-Stage4 |
6.49139997310755E-09 |
| Stage2-vs-Stage3 |
4.451900E-02 |
| Stage2-vs-Stage4 |
3.704000E-03 |
| Stage3-vs-Stage4 |
1.211610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.239800E-01 |
| Normal-vs-AfricanAmerican |
2.470800E-01 |
| Normal-vs-Asian |
3.471600E-01 |
| Caucasian-vs-AfricanAmerican |
9.709800E-02 |
| Caucasian-vs-Asian |
2.139200E-01 |
| AfricanAmerican-vs-Asian |
7.792500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.039200E-01 |
| Normal-vs-Female |
2.320800E-01 |
| Male-vs-Female |
2.306400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.426600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.655650E-01 |
| Normal-vs-Age(61-80Yrs) |
8.568200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.606800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.772200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.736000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.194000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.572200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.732600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.213400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.975600E-04 |
| Normal-vs-Grade 2 |
2.655600E-03 |
| Normal-vs-Grade 3 |
2.707200E-01 |
| Normal-vs-Grade 4 |
1.163880E-04 |
| Grade 1-vs-Grade 2 |
1.678190E-01 |
| Grade 1-vs-Grade 3 |
4.228300E-04 |
| Grade 1-vs-Grade 4 |
1.32440000000233E-06 |
| Grade 2-vs-Grade 3 |
1.81942999999407E-05 |
| Grade 2-vs-Grade 4 |
3.73289954502809E-10 |
| Grade 3-vs-Grade 4 |
1.324020E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.13219999999348E-05 |
| Normal-vs-ccB subtype |
1.967230E-01 |
| ccA subtype-vs-ccB subtype |
2.85150000278733E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.417200E-01 |
| Normal-vs-N1 |
3.625600E-01 |
| N0-vs-N1 |
2.765200E-01 |
|
|
